The pathogenesis of villous
patients. The second part of the study compared treated coeliac disease with untreated coeliac disease. Treated coeliac disease cases had normal amounts of NSE staining, which were the same as normal controls. These findings suggest that neuroproliferation is a feature of coeliac disease and Crohn's disease. Both 
Methods
The cases were selected from the files of the Central Pathology Laboratory, St James's Hospital. Biopsy specimens were used in cases of coeliac disease (10) and normal controls (16). The cases of coeliac disease all had complete villous atrophy with a considerable increase in intraepithelial lymphocytes. Surgical resection specimens were used for cases of Crohn's disease (13) and carcinoma ofthe duodenum (8) . The cases of Crohn's disease were from surgical resection specimens of the small intestine usually removed for intestinal obstruction. All were unequivocal cases of Crohn's disease with granulomas identified in part of the specimen. In the Crohn's disease cases areas that contained active disease were used, however, areas of ulceration were excluded. In the carcinoma cases areas immediately adjacent to the tumour were selected for analysis. In both these diseases these areas were selected so that muscularis mucosa and lamina propria could be easily identified.
Initially, several different immunoperoxidase stains were used-S 100 protein, neurofilament, PGP9.5, actin, and neurone-specific enolase (NSE). NSE was found to specifically stain filamentous structures when compared with S100, neurofilament, and PGP9.5. When compared with the actin stain, the filamentous structures stained by the NSE did not stain for actin, proving that they were not of muscular origin. A monoclonal mouse antibody to NSE (Biogenex) was used here. It reacts with human gamma-gamma enolase, which is present primarily in neurons, in normal and in neoplastic neuroendocrine cells.3 It can also be expressed to some extent by platelets, megakaryocytes, T cells, and striated and smooth muscle cells. Platelets or megakaryocytes were not seen in the mucosa, moreover, filamentous structures were present in our slides not granular/cellular material. The possibility that the structures measured might be muscular in origin was ruled out by using the actin stain as a positive control for muscle fibres. All specimens were formalin fixed and paraffin wax embedded. Sections were cut at 4 microns thickness and stained with an antibody for NSE using a standard indirect biotinstreptavidin immunoperoxidase method. Briefly, sections were dewaxed and rehydrated through xylene and graded alcohols. Endogenous peroxidase was blocked with methanol/H202. Non-specific binding was blocked with 0.1% bovine serum albumin. Sections were incubated with appropriate primary antiserum (one hour at room temperature), followed by biotinylated rabbit-antimouse (1/300 dilution) (Dakopats) and then streptavidin-peroxidase (1/400 dilution) (Dakopats). The chromogen used was DAB/H202, and sections were counterstained with haematoxylin. A negative control was used for each slide.
The amount of staining present at X25 magnification in an area of the mucosa immediately above the muscularis mucosa was evaluated using the Quantimet 570 image analyser. This image analyser can select out areas of brown immunoperoxidase staining and evaluate the area of the field covered by the stain. This value is expressed as a fraction of the field. This area was chosen because it does not contain villi and so that its shape would not change according to whether villi were present or not. Four fields were evaluated in each case in a blind fashion.
A second arm of the study aimed to see if there was a difference between treated and untreated coeliac disease patients. Cases were selected by reviewing the histological appearance. Patients were allocated to the group of treated coeliac disease patients only if their duodenal mucosa was absolutely normal with no increase in intraepithelial lymphocytes. Group 1 contained treated coeliac disease cases (3 patients), group 2 contained untreated coeliac cases (13 patients), group 3 contained peptic duodenitis cases (11 cases), and group 4 had normal controls (9 patients). In addition, the diameter of the nerves was measured to see if they were hypertrophic rather than hyperplastic. Figure 3 gives the results from the comparison of treated and untreated coeliac patients. The mean of the treated coeliac group was 0-036; of the untreated coeliac group 0-0823; of the duodenitis group was 0-011, and of controls was 0-014. These showed that there was a statistically significant difference between the group of untreated coeliac disease patients and normal controls (Wilcoxon/ Kruskal-Wallis tests, rank sum). The difference between untreated coeliac disease patients and the peptic duodenitis group was just outside statistical significance. The mean diameter of the nerve fibres in each group was as follows: normal controls -2-2, untreated 
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Results Figure 1 shows a flattened duodenal mucosa from a patient with coeliac disease that has been stained with NSE. There are prominent nerve filaments throughout the mucosa. Figure  2 shows the results of the first part of the study. differences between the groups was not statistically significant using the Student's t test.
Discussion
The results in this study show that there is increased staining of NSE in the mucosa in both coeliac disease and Crohn's disease. While hypertrophic nerves have been seen in the submucosa in colon with Crohn's disease, the presence of increased nerve filaments in the mucosa in coeliac disease and Crohn's disease has not been reported before. It is noteworthy that the hypertrophic nerves seen in Crohn's disease are very different from the phenomen reported here. In Crohn's disease there are abnormally large and irregularly shaped nerve trunks in various bowel layers but sparing the mucosa, a very different finding from the proliferation of small nerve filaments described here in the mucosa.4 A common feature in both of these diseases is the presence of chronic inflammation. Neuroproliferation is not a feature that is commonly commented on in chronic inflammation and there are only two reports of its involvement in chronic inflammation -in the proctocolitis associated with lymphogranuloma venereum5 and also in the obliterated appendix, which is thought to be a result of repeated minimal subclinical attacks of inflammation. The cause of the architectural abnormalities in coeliac disease is unknown. The centre of the villus is made up of a delicate neurovascular/ muscular core. Changes in neural interactions in the mucosa could bring about a change in villus growth and maintenance of a normal structure. When the values are reviewed, the value for coeliac disease is 00323 versus 0.0218 for Crohn's disease. Although the difference does not reach statistical significance the value for coeliac disease is 50% larger than that for Crohn's disease. It might be postulated that this extra amount of neuroproliferation is necessary to produce the architectural abnormalities seen in coeliac disease, which is not a feature of Crohn's disease.
In conclusion, NSE staining is significantly increased in the mucosa of patients with coeliac disease and Crohn's disease, a feature that has not been reported before. This change is more noticeable in coeliac disease than in Crohn's disease. This increase seems to be associated with chronic inflammation as it returns to normal once coeliac disease is treated. The presence of neuroproliferation in both of these diseases offers new approaches to their study as their causes and pathogenesis are as yet incompletely understood. 
